RE: Belluscura20 Sep 2022 08:25
Second BELL RNS today !
20 September 2022
Belluscura plc
("Belluscura" or the "Company")
Belluscura signs agreement with leading distributor in the US
Belluscura, a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that it has signed a distribution agreement with a leading Durable Medical Equipment ("DME") provider and distributor in the US.
The DME has been providing oxygen therapy in the home setting for over 50 years and supplies both online and through over 1,000 bricks and mortar locations throughout the US.
The agreement is for the distribution of the next generation X-PLOR®, with its new Nomad Biometric™ App where patients can connect other Bluetooth® devices such as their iPhone® or Android phone, Nonin® or Masimo® pulse oximeters, and Fitbit® wearables.
Robert Rauker, CEO of Belluscura plc, said:
"This agreement, with one of the largest supplemental oxygen providers in the US, significantly increased our coverage across the country, and will give more patients access to our best-in-class devices."
ENDS